Sign in

Research summary ·

Sarcopenia and outcomes after revascularization for peripheral arterial disease: a scoping review.

Written based on 1 research study on PubMed, searched on 13 Nov 2026.

What was studied

This review looked at muscle loss in people with peripheral artery disease. This kind of muscle loss is called sarcopenia. The review set out to study people having a procedure to restore blood flow. This was a scoping review, which maps what research exists on a topic. The team searched for papers in English or Chinese up to June 30, 2025.

What they found

The review brought together the results of a set of earlier studies. How common muscle loss was differed a lot from study to study. Most studies judged muscle loss from scans alone. They did not also test muscle strength or how well people moved. Even so, muscle loss seen on scans was linked to more deaths after surgery. It was also linked to more heart and blood vessel events. The health of the legs was also worse in these people.

What it means for patients

The authors say muscle loss is common in people with this disease. They see it as a possible risk factor for poor results after surgery. They want one shared way to test for muscle loss. They say this test should cover several sides of muscle health.

Why it is not certain yet

The studies used different rules to decide who had muscle loss. Their methods also varied a great deal. The authors say this limits how widely the results apply. They call for high-quality studies that follow people forward in time. A review can only be as good as the studies in it.

Source

Sarcopenia and outcomes after revascularization for peripheral arterial disease: a scoping review.

PubMed · PMID 42876520

We restate facts from the source record in our own words. The original wording belongs to its publisher.

This page is not medical advice. Talk to your doctor about your own care.

Back to Peripheral artery disease publications